9608
X.-Q. Li et al. / Tetrahedron 61 (2005) 9600–9610
4.1.7. Compound 16. To a solution of 14 (0.33 g,
0.50 mmol) in pyrrolidine (4 mL) were added Pd(PPh3)4
(30.0 mg, 0.040 mmol, 8%) and 15 (65.0 mg, 0.75 mmol).
The mixture was stirred at 80 8C for 4 h and then
concentrated in vacuo. The resulting residue was triturated
with CH2Cl2 (50 mL). The organic phase was washed with
hydrochloric acid, water, brine, and dried. After the solvent
was removed, the crude product was purified by column
chromatography (EtOAc/CH3OH 50:1) to obtain 16 as a
yellow solid (0.29 g, 85%). Mp 95–96 8C. 1H NMR
(CDCl3): d 1.57 (s, 6H), 3.69–3.89 (m, 24H), 3.98–4.01
(m, 4H), 4.17–4.25 (m, 4H), 4.48 (d, JZ9.0 Hz, 1H), 6.61
(d, d, J1Z3.0 Hz, J2Z9.0 Hz, 1H), 6.67 (d, JZ8.1 Hz, 1H),
6.73–6.75 (m, 2H), 724–7.28 (m, 2H), 7.83 (d, d, J1Z
3.0 Hz, J2Z8.1 Hz, 2H). EI-MS: m/z: 668 [M]C. Elemental
Anal. Calcd (%) for C37H48O11 (668.77): C, 66.45; H, 7.23.
Found: C, 66.59; H, 7.08.
114.6, 116.7, 118.2, 125.2, 125.2, 126.7, 151.5, 152.4,
152.8, 153.8, 154.3, 156.5, 170.4. IR (cmK1): n 3211, 2926,
2855, 1697, 1594, 1264, 1080, 768. MALDI-HRMS: m/z:
911.4406 [MC Na]C. Calcd for C48H64N4O12: 911.4413.
4.1.11. Compound 22. A solution of 2024 (1.04 g,
2.00 mmol), 2125 (0.74 g, 2.00 mmol), K2CO3 (1.10 g,
8.00 mmol), and KI (0.10 g) in DMF (20 mL) was stirred
at 80 8C for 12 h and then cooled. The insoluble materials
were filtered off and the solvent was removed under reduced
pressure. The residue was triturated with AcOEt (150 mL).
The organic phase was washed with aqueous HCl solution,
NaHCO3 solution, water, brine, and dried (Na2SO4). After
the solvent was removed in vacuo, the crude product was
recrystallized from AcOEt to obtain 22 (1.44 g, 90%) as a
white solid. Mp 154–156 8C. 1H NMR (CDCl3): d 1.26–1.36
(m, 39H), 1.65–1.77 (m, 4H), 3.67 (t, JZ7.2 Hz, 2H), 3.91
(t, JZ6.9 Hz, 2H), 6.75 (d, JZ7.8 Hz, 2H), 7.05–7.09 (m,
8H), 7.21–7.26 (m, 6H), 7.70–7.71 (m, 2H), 7.82–7.84 (m,
2H). MALDI-MS: m/z: 812 [MC Na]C. Elemental Anal.
Calcd (%) for C55H67NO3$0.25H2O (794.64): C, 83.13; H,
8.58; N, 1.76. Found: C, 83.31; H, 8.54; N, 1.33.
4.1.8. Compound 17. To a solution of 16 (0.29 g,
0.43 mmol) in benzene (10 mL) was added NaOH
(52.0 mg, 1.30 mmol). The mixture was refluxed for 4 h,
cooled and washed with water, brine, and dried. After the
solvent was removed in vacuo, the residue was chromato-
graphed (EtOAc/CH3OH 50:1) to afford 17 as a white solid
4.1.12. Compound 23. Hydrazine hydrate (2.0 mL, 85%)
was added to a solution of 22 (1.10 g, 1.40 mmol) in ethanol
(30 mL). The solution was refluxed for 3 h and then
concentrated in vacuo to give a residue, which was triturated
with chloroform (100 mL). The organic phase was washed
with water, brine, and dried (NaSO4). After removal of the
solvent under reduced pressure, the crude product was
recrystallized from AcOEt to afford compound 23 as a white
1
(0.26 g, 98%). Mp 92–93 8C. H NMR (CDCl3): d 3.21 (s,
1H), 3.67–3.92 (m, 24H), 3.97–4.01 (m, 4H), 4.21–4.25 (m,
4H), 4.48 (d, JZ9.0 Hz, 1H), 6.56 (d, d, J1Z3.0 Hz, J2Z
9.0 Hz, 1H), 6.75 (d, d, J1Z3.3 Hz, J2Z7.8 Hz, 2H), 6.82
(d, JZ2.7 Hz, 1H), 728–7.29 (m, 2H), 7.85 (d, d, J1Z
2.4 Hz, J2Z8.1 Hz, 2H). EI-MS: m/z: 610 [M]C. Elemental
Anal. Calcd (%) for C34H42O10 (610.69): C, 66.87; H, 6.93.
Found: C, 66.90; H, 6.89.
1
solid (0.90 g, 91%). Mp 94–96 8C. H NMR (CDCl3): d
1.26–1.43 (m, 39H), 1.73–1.78 (m, 4H), 2.68 (t, JZ7.2 Hz,
2H), 3.92 (t, JZ6.6 Hz, 2H), 6.75 (d, JZ9.0 Hz, 2H), 7.06–
7.10 (m, 8H), 7.21–7.26 (m, 6H). ESI-MS: m/z: 610 [MC
H]C. Elemental Anal. Calcd (%) for C47H65NO$0.25H2O
(664.54): C, 84.94; H, 9.96; N, 2.11. Found: C, 84.99; H,
9.98; N, 1.55.
4.1.9. Compound 18. A solution of 2-amino-5-iodo-6-
methyl-3H-pyrimidin-4-one23 (3.00 g, 12.0 mmol) and n-n-
octyl isocyanate (2 mL) in THF (200 mL) was heated under
reflux for 24 h. After work-up,11a the crude product was
purified by column chromatography (CH2Cl2/MeOH 30:1)
to afford 18 (3.50 g, 73%) as a white solid. Mp 150–152 8C.
1H NMR (CDCl3): d 0.85–0.88 (m, 3H), 1.27–1.32 (m,
10H), 1.58–1.62 (m, 2H), 2.45 (s, 3H), 3.26 (m, 2H), 9.83 (s,
1H), 11.66 (s, 1H), 13.44 (s, 1H). EI-MS: m/z: 406 [MC].
Elemental Anal. Calcd (%) for C14H23IN4O2 (406.27): C,
41.39; H, 5.71; N, 13.79. Found: C, 41.30; H, 5.71; N, 13.52.
4.1.13. Compound 26. A solution of compounds 23 (0.45 g,
0.68 mmol), 24 (0.18 g, 0.68 mmol), and 25 (0.05 g,
0.68 mmol) in DMF (10 mL) was stirred at 120 8C for 4 h.
Upon cooling, the insoluble materials were filtered off and
the solvent was removed in vacuo. The resulting residue was
triturated in chloroform (50 mL) and the solution was
washed with water, brine, and dried (MgSO4). The solvent
was then removed and the crude product purified by column
chromatography (CH2Cl2/MeOH 50:1) to give 26 as a pink
4.1.10. Compound 11. A suspension of 17 (0.31 g,
0.50 mmol), 18 (0.31 g, 0.77 mmol), Pd(PPh3)2Cl2 (30 mg,
6%), and CuI (10 mg, 10%) in THF (10 mL) and NEt3
(1.5 mL) was stirred at rt for 5 h and then concentrated
under reduced pressure. The residue was triturated with
CH2Cl2 (50 mL). After work-up, the resulting residue was
purified by column chromatography (CH2Cl2/CH3OH 20:1)
to produce 11 (0.14 g, 31%) as a yellow solid. Mp 150–
1
solid (0.17 g, 25%). Mp 242–243 8C. H NMR (CDCl3): d
1.25–1.39 (m, 39H), 1.71–1.75 (m, 4H), 3.91 (t, JZ6.6 Hz,
2H), 4.19 (t, JZ7.2 Hz, 2H), 5.00 (s, 2H), 6.75 (d, JZ
8.4 Hz, 2H), 7.05–7.09 (m, 8H), 7.22 (d, JZ8.7 Hz, 6H),
8.78 (s, 4H). MALDI-MS: m/z: 989 [MC Na]C. Elemental
Anal. Calcd (%) for C63H70N2O7 (967.24): C, 78.23; H,
7.29; N, 2.90. Found: C, 78.45; H, 7.01; N, 2.76.
1
152 8C. H NMR CDCl3): d 0.84 (t, JZ6.6 Hz, 3H), 1.23–
1.28 (m, 12H), 2.49 (s, 3H), 3.22–3.29 (m, 2H), 3.65–3.84
(m, 24H), 3.96–4.02 (m, 4H), 4.21–4.23 (m, 4H), 6.35 (d,
JZ9.0 Hz, 1H), 6.56 (d, d, J1Z3.3 Hz, J2Z9.0 Hz, 1H),
6.71–6.78 (m, 2H), 6.95 (d, JZ3.3 Hz, 1H), 7.26–7.29 (m,
2H), 7.84 (d, d, J1Z2.1 Hz, J2Z8.7 Hz, 2H), 10.13 (t, JZ
5.1 Hz, 1H), 11.83 (s, 1H), 13.45 (s, 1H). 13C NMR
(CDCl3): d 14.2, 18.7, 22.7, 27.0, 29.3, 29.4, 29.6, 29.7,
31.9, 40.2, 53.2, 68.0, 68.5, 69.7, 69.7, 69.8, 70.6, 70.8,
70.9, 71.0, 71.1, 93.7, 104.3, 105.6, 105.7, 113.1, 113.4,
4.1.14. Compound 19. A suspension of 26 (0.28 g,
0.29 mmol) in thionyl chloride (5 mL) was refluxed for
6 h and then concentrated in vacuo to afford compound 27
as an oil, which was used directly for next step. To a stirred
solution of 2811a (94 mg, 0.29 mmol), triethylamine
(0.8 mL) and DMAP (10 mg) in CHCl3 (15 mL) was
added a solution of the above 27 in chlroform (5 mL). The